Investigation of CTX-M type beta-lactamases in Klebsiella pneumoniae clinical isolates by phenotypic and molecular methods;Klebsiella pneumoniae klinik izolatlarinda CTX-M tipi beta-laktamazlarin fenotipik ve moleküler yöntemlerle araştirilmasi

Mikrobiyoloji Bulteni

Volumn 43, Issue 4, 2009, Pages 553-562

  Tikveşll, Soner ^a   Cevahir, Nural ^a   Kalell, Ilknur ^b  

^a Mikrobiyoloji Laboratuvari   (Turkey)

^b PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cefotaximase; CTX M; Klebsiella pneumoniae; PCR; RAPD PCR

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MALE; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHENOTYPE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

EID: 73249153281     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Stürenburg E, Mack D. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003;47:273-95.
2. Bush K. Is it important to identify extended spectrum beta-lactamase producing isolates. Eur J Clin Microbiol Infect Dis 1996;15:361-4.
3. Coudron PE, Moland S, Sander CC. Occurrence and detection of extended spectrum beta-lactamases in members of the family Enterobacteriaceae at a Veterans Medical Center. J Clin Microbiol 1997;35:2593-6.
4. Gür D. ESBL'lerin genel özellikleri ve ESBL tipleri, s: 5-11. Yeni ve Yeniden Gündeme Gelen Infeksiyonlar. 2004. Bilimsel Tip Yayinevi, Ankara.
5. th ed. Lippincott Company, Philadelphia.
6. Clinical and Laboratory Standards Institute (CLSI). Antimikrobik duyarlilik testleri için uygulama standartlari. (Gür D, Çeviri editörü), Onsekizinci Bilgi Eki. M100-S18, 2008. Türk Mikrobiyoloji Cemiyeti Yayini, Istanbul.
7. Jeong SH, Bae IK. Dissemination of transferable CTX-M-type extended spectrum beta-lactamase producing Escherichia coli in Korea. J Applied Microbiol 2005;98:921-7.
8. Aktaş, Z, Kipritçi Ö. Transplantasyon ünitesinde yatan hastalardan izole edilen Pseudomonas aeruginosa suşlarinin PAPD-PCR yöntemiyle tiplendirilmesi. Türk Mikrobiyol Cem Derg 2006;36:88-93.
9. Podscun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors. Clin Microbiol Rev 1998;11:589-603.
10. Jacoby CA, Medeiros AA. More extended spectrum beta-lactamases. Antimicrob Agents Chemother 1991; 35:1697-704.
11. Özsoy MF, Öncül O, Yildirim A, Pahsa A. Genişlemiş spektrumlu beta-laktamazlar: klinik önemi ve getirdiǧi sorunlar. FLORA 2001;6:3-9.
12. Livermore DM, Hawkey PM. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 2005; 56:451-4.
13. Abacioǧlu YH, Yücesoy M, Gülay Z, Yuluǧ N. "Extended spectrum β-lactamases" saptanmasinda E testi ile çift disk sinerji yönteminin karşilaştirilmasi. Infeksiyon Derg 1995;9:93-8.
14. Eskitürk A, Korten V, Söyletir G. Akut bakim gerektiren hastalarda gelişen infeksiyonlardan izole edilen Klebsiella türlerinde antibakteriyel duyarlilik paternlerinin ve geniş spektrumlu beta-laktamaz sikliǧinin araştirilmasi. ANKEM 1996; 10:14-8.
15. Gülay Z, Biçmen MK, Yuluǧ N. Geniş letilmiş spektrumlu beta-laktamaz varliǧinin saptanmasinda kullanilan çeşitli yöntemlerin deǧerlendirilmesi. ANKEM 1998;12:514-21.
16. Akçam FZ, Gönen I, Kaya O, Yayli G. Hastane infeksiyonu etkeni çeşitli gram negatif bakterilerde genişlemiş spektrumlu beta-laktamaz yapiminin iki yöntemle araştirilmasi. Klimik Dergisi 2004;17:47-50.
17. Kim YK, Pai H, Lee HJ. Bloodstream infections by extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002;46:1481-91.
18. Balkan II, Gençer S, Batirel A, Özer S. Florokinolonlara karşi direnç gelişimine katkida bulunan çeşitli risk faktörlerinin analizi. FLORA 2005;10:65-73.
19. Gioia SB, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother 2000;45:183-9.
20. Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Sothern and Western Europe in 1997-1998. J Antimicrob Chemother 2000;45:183-9.
21. Mumcuoǧlu I, Gündüz T, Baydur H. Escherichia, Klebsiella ve Proteus suşlarinda genişlemiş spektrumlu betalaktamaz varliǧi ve çeşitli antibiyotiklere direnç durumu. ANKEM 2004;18:9-11.
22. Aktaş Z, Gönüllü N, Schneider I, Bal C, Bauernfeind A. Detection of CTX-M-15 type extended spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient. Mikrobiyol Bul 2005; 39:421-9.
23. th European Congress of Clinical Microbiology and Infectious Diseases, 10-13 May 2003, Glasgow, UK. Congress and Abstract Book, P-1564.
24. Aktaş Z, Gönüllü N, Şalcioǧlu M, Bal Ç. E.coli ve K.pneumoniaé de geniş lemiş. spektrumlu beta-laktamazlarin "isoelectric focusing" ve PCR ile araştirilmasi. 6. Antimikrobik Kemoterapi Günleri-Klinik Laboratuvar Uygulamalari ve Yenilikler. Istanbul 2004. Program ve Özet Kitabi, P-19.
25. Paterson DL, Hujer KM, Hujer AM. Extended spectrum beta-lactamases in K.pneumoniae bloodstream isolates from seven countries: Dominance and widespread prevalence of SHV and CTX-M type beta lactamases. Antimicrob Agent Chemother 2003;47:3554-60.
26. Gür D, Gülay G, Arikan Akan Ö, et al. Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study. Mikrobiyol Bul 2008;42:537-44.